IRIS
SAMMARTINO, JOSE' CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 644
EU - Europa 365
AS - Asia 168
AF - Africa 1
Totale 1.178
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 637
IE - Irlanda 147
CN - Cina 102
IT - Italia 97
FI - Finlandia 54
SG - Singapore 38
DE - Germania 36
JP - Giappone 16
ES - Italia 7
IN - India 6
RU - Federazione Russa 5
SE - Svezia 5
CA - Canada 4
BE - Belgio 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
FR - Francia 2
HK - Hong Kong 2
MX - Messico 2
RO - Romania 2
EG - Egitto 1
GB - Regno Unito 1
IL - Israele 1
JM - Giamaica 1
LT - Lituania 1
MY - Malesia 1
PK - Pakistan 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.178
Salva come PNG Salva come JPEG
Città #
Dublin 139
Chandler 121
Ashburn 74
Boardman 67
New York 57
Helsinki 54
Shanghai 49
Singapore 24
Princeton 20
Lawrence 19
Pavia 19
Medford 18
Milan 18
Beijing 15
Seattle 15
Wilmington 13
Ann Arbor 8
Lecce 8
Rome 8
Washington 8
Los Angeles 7
Nanjing 7
Munich 6
Tokyo 6
Utrera 6
Shenyang 5
Dallas 4
Dearborn 4
Hangzhou 4
Nanchang 4
Santa Clara 4
Bologna 3
Boves 3
Brussels 3
Changsha 3
Falkenstein 3
Ferrara 3
Frankfurt am Main 3
Gallarate 3
Naples 3
Piscataway 3
Toronto 3
Boffalora sopra Ticino 2
Chicago 2
Cluj-Napoca 2
Copertino 2
Fairfield 2
Hebei 2
Hermosillo 2
Hong Kong 2
Hyderabad 2
Jinan 2
Olomouc 2
Pune 2
Redwood City 2
Serrone 2
Taranto 2
Barcelona 1
Bromma 1
Cairo 1
Chiasso 1
Cinisello Balsamo 1
Corteolona 1
Delhi 1
Florence 1
Gatchina 1
Gunzenhausen 1
Haifa 1
Hanover 1
Houston 1
Huddinge 1
Islamabad 1
Jiaxing 1
Kunming 1
Lodi 1
London 1
Lugano 1
Minoh 1
Nandyal 1
Norwalk 1
Nuremberg 1
Nürnberg 1
Oklahoma City 1
Ottawa 1
Quzhou 1
Rockville 1
Rovello Porro 1
San Diego 1
San Francisco 1
Shenzhen 1
St Petersburg 1
Tianjin 1
Yekaterinburg 1
Totale 910
Salva come PNG Salva come JPEG
Nome #
Targeting iron uptake pathway for the development of novel antitubercular drugs. 60
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 54
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 48
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis 46
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 45
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 44
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 44
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 41
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 39
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 38
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 38
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 37
19n01, a Broadly Neutralizing Antibody Against Omicron BA.1, BA.2, BA.4/5, and Other SARS-CoV-2 Variants of Concern 35
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 35
First triclosan-based macrocyclic inhibitors of InhA enzyme 34
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 34
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents 33
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 33
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients 32
P146 New weapons are necessary to fight Mycobacterium abscessus 31
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 29
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 29
Immune response to bnt162b2 in solid organ transplant recipients: Negative impact of mycophenolate and high responsiveness of sars-cov-2 recovered subjects against delta variant 23
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 19
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 19
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 19
Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects 19
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 19
Immunity to SARS-CoV-2 up to 15 months after infection 17
Annotation process, guidelines and text corpus of small non-coding RNA molecules: The MiNCor for microRNA annotations 17
Macrophages and monocytes: “trojan horses” in covid-19 16
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 16
Effect of different titanium dental implant surfaces on human adipose mesenchymal stem cell behavior. An in vitro comparative study 16
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 15
Characterization of CCP: Can We Use Past Convalescent Plasma from COVID-19 Patients for Treatment of New Emerging Variants? 14
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients 14
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice 14
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment 13
Neutralizing antibody levels against SARS-CoV-2 variants of concern Delta and Omicron in vaccine breakthrough-infected blood donors 13
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 12
Effect of different surface treatments on titanium dental implant micro-morphology 12
Genotyping of Toxoplasma gondii strain directly from human CSF samples of congenital toxoplasmosis clinical case 11
Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital 11
mRNA BNT162b Vaccine Elicited Higher Antibody and CD4+ T-Cell Responses than Patients with Mild COVID-19 11
Comparative analysis of the chemical composition and microstructure conformation between different dental implant Bone Drills 10
Local delivery of the hemostatic agent tranexamic acid in chronically anticoagulated patients 10
Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study 10
White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds 9
Clinical Influence of Micromorphological Structure of Dental Implant Bone Drills 9
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant 7
Effect of Low Copper Doping on the Optical, Cytocompatible, Antibacterial, and SARS-CoV-2 Trapping Properties of Calcium Phosphate Glasses 7
Fitness cost of rifampin resistance in Neisseria meningitidis: In Vitro study of mechanisms associated with rpoB H553Y mutation 6
Micro-scale surface patterning of titanium dental implants by anodization in the presence of modifying salts 6
Platelet-rich plasma counteracts detrimental effect of high-glucose concentrations on mesenchymal stem cells from Bichat fat pad 6
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technology 5
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant 2
High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development 2
Totale 1.288
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 6 1 6 10 2 8 7 3
2020/202135 1 1 1 2 7 2 4 15 1 0 0 1
2021/2022100 0 1 0 9 1 1 3 6 6 12 11 50
2022/2023448 32 40 3 29 27 24 0 16 240 13 21 3
2023/2024472 44 87 32 23 38 124 35 24 2 16 12 35
2024/2025148 27 67 15 16 23 0 0 0 0 0 0 0
Totale 1.288